VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE
Open Access
- 1 January 2013
- journal article
- review article
- Published by Hematology Section, Dept. of Radiological Science and Hematology, Catholic University, Rome, Italy in Mediterranean Journal of Hematology and Infectious Diseases
- Vol. 5 (1), e2013057
- https://doi.org/10.4084/mjhid.2013.057
Abstract
The survival of patients with thalassemia major has progressively improved with advances in therapy; however, osteoporosis and cardiac dysfunction remain frequent complications. Adequate circulating levels of vitamin D are essential for optimal skeletal health and reducing fracture risk. Vitamin D deficiency and insufficiency is reported to be high in thalassemic patients in many countries despite the presence of good sunshine and routine prescription of 400–1,000 IU vitamin D per day. The risk of vitamin D deficiency in thalassemia and its relation to bone disease; including osteoporosis, rickets, scoliosis, spinal deformities and fractures as well as to cardiac dysfunction is discussed in this mini-review. Monitoring and maintaining normal serum level of 25-OH vitamin D through oral intake of vitamin D and early correction of VDD by oral or parental use of vitamin D may significantly improve bone mineral accretion and ameliorate cardiac function. The survival of patients with thalassemia major has progressively improved with advances in therapy; however, osteoporosis and cardiac dysfunction remain frequent complications. Adequate circulating levels of vitamin D are essential for optimal skeletal health and reducing fracture risk. Vitamin D deficiency and insufficiency is reported to be high in thalassemic patients in many countries despite the presence of good sunshine and routine prescription of 400–1,000 IU vitamin D per day. The risk of vitamin D deficiency in thalassemia and its relation to bone disease; including osteoporosis, rickets, scoliosis, spinal deformities and fractures as well as to cardiac dysfunction is discussed in this mini-review. Monitoring and maintaining normal serum level of 25-OH vitamin D through oral intake of vitamin D and early correction of VDD by oral or parental use of vitamin D may significantly improve bone mineral accretion and ameliorate cardiac function.Keywords
This publication has 59 references indexed in Scilit:
- Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North AmericaBritish Journal of Haematology, 2009
- Bone Disease in Thalassemia: A Frequent and Still Unresolved ProblemJournal of Bone and Mineral Research, 2009
- Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia majorBritish Journal of Haematology, 2008
- Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis DBritish Journal of Nutrition, 2008
- Resurrection of vitamin D deficiency and ricketsJCI Insight, 2006
- Why the optimal requirement for Vitamin D3 is probably much higher than what is officially recommended for adultsThe Journal of Steroid Biochemistry and Molecular Biology, 2004
- Regulation of 25-hydroxyvitamin D3-1α-hydroxylase and production of 1α,25-dihydroxyvitamin D3 by human dendritic cellsBlood, 2003
- Hypoparathyroidism with Extensive Intracerebral Calcification in Patients with ß-Thalassemia MajorJournal of Pediatric Endocrinology and Metabolism, 2003
- Interactions between GH, IGF-I, Glucocorticoids, and Thyroid Hormones during Skeletal GrowthPediatric Research, 2002
- Local action of phosphate depletion and insulin-like growth factor 1 on in vitro production of 1,25-dihydroxyvitamin D by cultured mammalian kidney cells.JCI Insight, 1994